Catalyst Wire Dossier Catalyst Wire Dossier

MEDI-565

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI-565, covering 2015-03-03 to 2015-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas [Phase 1]

See pricing